Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 25 entries
View as:

Trial of IW-9179 in Patients With Diabetic Gastroparesis (DGP)

Phase: N/A Priority: Normal
NCT ID: NCT02289846 Org: User:
Start: 10/31/14 End: 12/31/15 Due: 12/31/16

A Study of MD-7246 to Treat Abdominal Pain in Patients With Diarrhea-predominant Irritable Bowel Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT03931785 Org: User:
Start: 05/01/19 End: 03/11/20 Due: 03/11/21

Randomized, Double-blind, Dose-range-finding, Phase 2 Study of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

Phase: N/A Priority: Normal
NCT ID: NCT00460811 Org: User:
Start: 04/30/07 End: 04/30/08 Due: 04/30/09

Study to Evaluate the Effect of IW-3718 on the Pharmacokinetics of Oral Contraceptive, Levothyroxine, Glyburide, and Digoxin in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03856970 Org: User:
Start: 03/11/19 End: 07/03/19 Due: 07/03/20

Study to Evaluate Efficacy and Safety of IW-6118 in Patients Undergoing Third Molar Extraction

Phase: N/A Priority: Normal
NCT ID: NCT01107236 Org: User:
Start: 06/30/10 End: 08/31/10 Due: 08/31/11

Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

Phase: N/A Priority: Normal
NCT ID: NCT00938717 Org: User:
Start: 07/31/09 End: 09/30/10 Due: 09/30/11

Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs)

Phase: N/A Priority: Normal
NCT ID: NCT03561883 Org: User:
Start: 09/06/18 End: 11/06/20 Due: 11/06/21

Study of Oral MD-0727 Administered to Patients With Primary Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT00404001 Org: User:
Start: 11/30/06 End: 07/31/07 Due: 07/31/08

A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs)

Phase: N/A Priority: Normal
NCT ID: NCT03561090 Org: User:
Start: 06/20/18 End: 11/03/20 Due: 11/03/21

A Study of the Effect of Linaclotide on Abdominal Girth in Participants With Irritable Bowel Syndrome With Constipation (IBS-C)

Phase: N/A Priority: Normal
NCT ID: NCT02837783 Org: User:
Start: 12/21/16 End: 10/31/18 Due: 10/31/19

Phase 2a Study of IW-9179 to Treat Functional Dyspepsia

Phase: N/A Priority: Normal
NCT ID: NCT01712412 Org: User:
Start: 10/31/12 End: 03/31/14 Due: 03/31/15

Trial of Linaclotide in Patients With Chronic Idiopathic Constipation

Phase: N/A Priority: Normal
NCT ID: NCT02291679 Org: User:
Start: 10/31/14 End: 08/31/15 Due: 08/31/16

Phase 2 Study of MD-1100 Acetate Administered for 14 Days to Patients Meeting Criteria for Chronic Constipation

Phase: N/A Priority: Normal
NCT ID: NCT00306748 Org: User:
Start: 03/31/06 End: 08/31/06 Due: 08/31/07

Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

Phase: N/A Priority: Normal
NCT ID: NCT02559206 Org: User:
Start: 10/22/15 End: 09/30/16 Due: 09/30/17

A Trial of IW-3718 for 8 Weeks in Patients With Symptomatic Gastroesophageal Reflux Disease (GERD)

Phase: N/A Priority: Normal
NCT ID: NCT02637557 Org: User:
Start: 03/01/16 End: 04/26/17 Due: 04/26/18

Trial of Linaclotide in Patients With Chronic Constipation

Phase: N/A Priority: Normal
NCT ID: NCT00730015 Org: User:
Start: 08/31/08 End: 10/31/09 Due: 10/31/10

Dose-range-finding, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients With Chronic Constipation

Phase: N/A Priority: Normal
NCT ID: NCT00402337 Org: User:
Start: 11/30/06 End: 02/29/08 Due: 02/28/09

A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

Phase: N/A Priority: Normal
NCT ID: NCT03573908 Org: User:
Start: 06/20/18 End: 04/10/19 Due: 04/10/20

Phase 2 Study of MD-1100 Acetate on Gastrointestinal Transit in Patients With C-IBS

Phase: N/A Priority: Normal
NCT ID: NCT00258193 Org: User:
Start: 01/31/06 End: 09/30/06 Due: 09/30/07

An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation

Phase: N/A Priority: Normal
NCT ID: NCT00730171 Org: User:
Start: 09/30/08 End: 03/31/12 Due: 03/31/13

A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT03226899 Org: User:
Start: 07/19/17 End: 02/25/19 Due: 02/25/20

Ph2a Study to Evaluate IW-3718 in Patients With Gastroesophageal Reflux Not Completely Responsive to Proton Pump Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT02030925 Org: User:
Start: 02/28/14 End: 12/31/14 Due: 12/31/15

A Study of Single Ascending Doses of IW-3300 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05188261 Org: User:
Start: 01/18/22 End: 03/21/22 Due: 03/21/23

A Phase 2 Study of IW-3300 for the Treatment of Bladder Pain in Subjects With Interstitial Cystitis/Bladder Pain Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT05740007 Org: User:
Start: 03/28/23 End: 02/06/25 Due: 02/06/26

A Study of Multiple-ascending Doses of IW-3300 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05362695 Org: User:
Start: 05/17/22 End: 07/13/22 Due: 07/13/23